SCHEMBL4598004

SCHEMBL4598004

CCCC(N)NCCCN

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 1/20 0.36
GNAO1 P09471 1/20 0.36
GNAI1 P63096 1/20 0.36
DPP7 Q9UHL4 1/20 0.35
DNM1 Q05193 6/20 0.35
CASP2 P42575 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CA12 O43570 2/20 0.35
F13A1 P00488 2/20 0.35
CA2 P00918 2/20 0.35
CYP1A2 P05177 2/20 0.35
ALOX15 P16050 2/20 0.35
CA4 P22748 2/20 0.35
CA6 P23280 2/20 0.35
CA5A P35218 2/20 0.35
THPO P40225 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30802610 0.93 GNAI3 (0.42) GNAI3GNAO1GNAI1DPP7DNM1
SCHEMBL3672040 0.92 CA12 (0.44) CASP2MEN1KMT2ACA12F13A1
SCHEMBL10882426 0.91 GNAI3 (0.45) GNAI3GNAO1GNAI1DPP7DNM1
SCHEMBL10439956 0.86
SCHEMBL8644870 0.86 RRM1 (0.36) GNAI3GNAO1GNAI1DPP7TSHR
SCHEMBL308611 0.86 OPRM1 (0.39) DPP7CA12CA2ALOX15CA7
SCHEMBL6021971 0.85 GNAI3 (0.47) GNAI3GNAO1GNAI1DPP7DNM1
SCHEMBL27832222 0.84 OPRM1 (0.37) DPP7CA12CA2ALOX15CA7
SCHEMBL28158597 0.83 CA12 (0.39) DPP7CASP2MEN1KMT2ACA12
SCHEMBL28474328 0.82 GNAI3 (0.36) GNAI3GNAO1GNAI1DPP7DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1877419-A2 POLYMORPHIC AND AMORPHOUS SALT FORMS OF SQUALAMINE DILACTATE Genaera Corporation (US) 2008-01-16 EP claimed
WO-2006116309-A2 POLYMORPHIC AND AMORPHOUS SALT FORMS OF SQUALAMINE DILACTATE GENAERA CORPORATION (US) 2006-11-02 WO claimed
EP-1877419-A2 POLYMORPHIC AND AMORPHOUS SALT FORMS OF SQUALAMINE DILACTATE Genaera Corporation (US) 2008-01-16 EP disclosed
WO-2006116309-A2 POLYMORPHIC AND AMORPHOUS SALT FORMS OF SQUALAMINE DILACTATE GENAERA CORPORATION (US) 2006-11-02 WO disclosed
EP-1051244-A4 METHOD AND ARTICLES FOR TRANSFECTION OF GENETIC MATERIAL TOMALIA DONALD A (US) 2003-06-11 EP disclosed
EP-0912584-B1 NEW BIS-PLATINUM COMPLEXES WITH POLYAMINE LIGANDS AS ANTITUMOR AGENTS HOFFMANN LA ROCHE (CH) 2002-12-18 EP disclosed
EP-1051244-A1 METHOD AND ARTICLES FOR TRANSFECTION OF GENETIC MATERIAL THE DOW CHEMICAL COMPANY (US) 2000-11-15 EP disclosed
US-6022892-A Bis-platinum complexes with polyamine ligands as antitumor agents HOFFMAN-LA ROCHE INC. (US) 2000-02-08 US disclosed
WO-1999034908-A1 METHOD AND ARTICLES FOR TRANSFECTION OF GENETIC MATERIAL THE DOW CHEMICAL COMPANY (US) 1999-07-15 WO disclosed
EP-0912584-A2 NEW BIS-PLATINUM COMPLEXES WITH POLYAMINE LIGANDS AS ANTITUMOR AGENTS F. HOFFMANN-LA ROCHE AG (CH) 1999-05-06 EP disclosed
WO-1998003519-A9 NEW BIS-PLATINUM COMPLEXES WITH POLYAMINE LIGANDS AS ANTITUMOR AGENTS 1998-07-16 WO disclosed
WO-1998003519-A2 NEW BIS-PLATINUM COMPLEXES WITH POLYAMINE LIGANDS AS ANTITUMOR AGENTS F. HOFFMANN-LA ROCHE AG (CH) 1998-01-29 WO disclosed